PURPOSE: This study was designed to repair a recurrent rectovaginal fistula using a new surgical approach that incorporates a Surgisistrade mark mesh. METHODS: A 63-year-old female with a history of recurrent rectovaginal fistula, which was treated originally by a traditional mucosal advancement flap technique, underwent a surgical procedure in which a biocompatible mesh was incorporated into the repair. RESULTS: The patient was symptom-free one-year after the procedure. CONCLUSIONS: Surgery for recurrent rectovaginal fistula incorporating a Surgisistrade mark mesh can be used as an innovative option.
PURPOSE: This study was designed to repair a recurrent rectovaginal fistula using a new surgical approach that incorporates a Surgisistrade mark mesh. METHODS: A 63-year-old female with a history of recurrent rectovaginal fistula, which was treated originally by a traditional mucosal advancement flap technique, underwent a surgical procedure in which a biocompatible mesh was incorporated into the repair. RESULTS: The patient was symptom-free one-year after the procedure. CONCLUSIONS: Surgery for recurrent rectovaginal fistula incorporating a Surgisistrade mark mesh can be used as an innovative option.
Authors: K W A Göttgens; J Heemskerk; W van Gemert; R Smeets; L P S Stassen; G Beets; C G M I Baeten; S O Breukink Journal: Tech Coloproctol Date: 2014-03-28 Impact factor: 3.781
Authors: Matthew J Aungst; Jeremy J Bearss; Bridget S Lewis; John R Fischer; Michael R Bonhage; Johnnie Wright Journal: Int Urogynecol J Date: 2010-02-09 Impact factor: 2.894
Authors: Matthew J Aungst; John R Fischer; Michael R Bonhage; Todd S Albright; Kathleen A Noel; Johnnie Wright Journal: Int Urogynecol J Date: 2010-02-26 Impact factor: 2.894
Authors: J M Devesa; M Devesa; G R Velasco; R Vicente; F García-Moreno; A Rey; P López-Hervás; J Die; J M Molina Journal: Tech Coloproctol Date: 2007-05-25 Impact factor: 3.781